AIN Holdings Inc
TSE:9627
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
52 Week Range |
4 303
6 281
|
Price Target |
|
We'll email you a reminder when the closing price reaches JPY.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
AIN Holdings Inc
Cash Equivalents
AIN Holdings Inc
Cash Equivalents Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
Company | Cash Equivalents | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
---|---|---|---|---|---|---|
AIN Holdings Inc
TSE:9627
|
Cash Equivalents
ÂĄ49.4B
|
CAGR 3-Years
-3%
|
CAGR 5-Years
4%
|
CAGR 10-Years
10%
|
||
Sundrug Co Ltd
TSE:9989
|
Cash Equivalents
ÂĄ62.4B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
6%
|
||
Tsuruha Holdings Inc
TSE:3391
|
Cash Equivalents
ÂĄ65.6B
|
CAGR 3-Years
-17%
|
CAGR 5-Years
9%
|
CAGR 10-Years
19%
|
||
S
|
Sugi Holdings Co Ltd
TSE:7649
|
Cash Equivalents
ÂĄ78.2B
|
CAGR 3-Years
6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
4%
|
|
MatsukiyoCocokara & Co
TSE:3088
|
Cash Equivalents
ÂĄ111.7B
|
CAGR 3-Years
45%
|
CAGR 5-Years
21%
|
CAGR 10-Years
27%
|
||
Cosmos Pharmaceutical Corp
TSE:3349
|
Cash Equivalents
ÂĄ51.4B
|
CAGR 3-Years
1%
|
CAGR 5-Years
23%
|
CAGR 10-Years
7%
|
AIN Holdings Inc
Glance View
Ain Holdings, Inc. engages in the operation of dispensing pharmacies and drug stores. The company is headquartered in Sapporo, Hokkaido and currently employs 9,019 full-time employees. The firm has three business segments. The Pharmacy segment operates and franchises pharmacies, and provides consulting services related to opening pharmacies. Through its subsidiaries, this segment is also involved in the provision of consultation services for medical-related affairs and manpower dispatching of doctors and pharmacists, as well as the sale of generic drugs. The Retail segment operates cosmetics business and drugstores. The Others segment is engaged in the leasing of buildings and the sales of cosmetics.
See Also
What is AIN Holdings Inc's Cash Equivalents?
Cash Equivalents
49.4B
JPY
Based on the financial report for Jul 31, 2024, AIN Holdings Inc's Cash Equivalents amounts to 49.4B JPY.
What is AIN Holdings Inc's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
10%
Over the last year, the Cash Equivalents growth was 4%. The average annual Cash Equivalents growth rates for AIN Holdings Inc have been -3% over the past three years , 4% over the past five years , and 10% over the past ten years .